Wells Fargo Upgrades HEALTHSOUTH (HLS) to Outperform; Relative Valuation More Favorable

Wells Fargo upgraded HEALTHSOUTH (NYSE: HLS) from Market Perform to Outperform, price target range maintained at $20-$24.

Analyst, G ary Lieberman, said, "We are upgrading shares of HealthSouth based on a combination of absolute and relative valuation (near its 5 year trough) and risks (economic, financial and regulatory) that are low compared with its peers and with those the company has faced over the prior 3-5 years. We are increasing our 2013 EPS estimate to $1.43 from $1.41. The company has said that it expects to come in at or above the high end of its $1.32-1.39 guidance range."

For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.

Shares of HEALTHSOUTH closed at $18.54 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
• Rosenblatt Starts Amazon.com (AMZN) at Buy
• TD Cowen Reiterates Buy Rating on Broadcom Limited (AVGO), neutral into the print